Daiwa Securities Group
LRMR icon

Daiwa Securities Group’s Larimar Therapeutics LRMR Stock Holding History

Daiwa Securities Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29
Closed – – 1352
2022
Q3 		$0 Hold
29
– – ﹤0.01% 1364
2022
Q2 		$0 Hold
29
– – ﹤0.01% 1397
2022
Q1 		$0 Hold
29
– – ﹤0.01% 1395
2021
Q4 		$0 Hold
29
– – ﹤0.01% 1422
2021
Q3 		$0 Hold
29
– – ﹤0.01% 1329
2021
Q2 		$0 Hold
29
– – ﹤0.01% 1279
2021
Q1 		$0 Hold
29
– – ﹤0.01% 1278
2020
Q4 		$1K Buy
+29
New +$581 ﹤0.01% 1188
2019
Q4 		– Sell
-20
Closed – – 1228
2019
Q3 		$0 Hold
20
– – ﹤0.01% 1191
2019
Q2 		$0 Hold
20
– – ﹤0.01% 1220
2019
Q1 		$1K Buy
+20
New +$1.02K ﹤0.01% 1165

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Daiwa Securities Group's LRMR Position: Q4 2022 in Review

Daiwa Securities Group sold out of Larimar Therapeutics (LRMR) in Q4 2022, closing a stake of 29 shares.

Daiwa Securities Group first reported a position in LRMR in Q1 2019 and held it in 11 quarters. The position peaked at $1K in Q4 2020. 48 funds tracked by Wall St. Rank hold LRMR as of Q4 2022.

  • Daiwa Securities Group reported no remaining Larimar Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 29 Larimar Therapeutics shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Larimar Therapeutics in Q1 2019 and held it in 11 quarters.
  • Daiwa Securities Group's Larimar Therapeutics position peaked at $1K in Q4 2020.
  • 48 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.